This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. rose 9.9% to $1.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.6% to 16,831.48 and the Dow Jones Industrial Average rising 0.8% to 40,524.79.
This was the stock's second consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 86.8% short of its 52-week high of $13.44, which the company achieved on May 16th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 1.7% to $154.36, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.96% to $22.12.
Trading volume totaled 801,287, compared to the 50-day average of 731,967.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 14, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。